Comparison of the effects of topical spironolactone solution and topical clindamycin solution on mild to moderate acne vulgaris treatment

Phase 3

Recruiting

• Conditions: Acne Vulgaris.; Acne vulgaris; L70.0

• Registration Number: IRCT20220720055503N1
• Lead Sponsor: Hamedan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 29 August 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

People with mild to moderate acne
18 years old and above

Exclusion Criteria

Pregnant and lactating women
Known hypersensitivity to clindamycin
History of using oral isotretinoin, laser or chemical peeling in the last 6 months
History of taking oral estrogen compounds in the last 3 months
History of using retinoid or antibiotics during the last month
History of using antimicrobial soaps or topical peels during the last two weeks
Chronic skin diseases such as psoriasis, lichen planus, vitiligo
Weakness of the immune system or the use of immunosuppressive drugs

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Acne Severity. Timepoint: Beginning of trial,1 month,2 months and 3 months after treatment. Method of measurement: Global Acne Grading System.

Secondary Outcome Measures

Name	Time	Method
Frequency and type of acne lesions. Timepoint: Beginning of trial,1 month,2 months and 3 months after treatment. Method of measurement: Counting type and number of lesions.